Enzo Biochem Inc/ US2941001024 /
29/07/2024 22:10:00 | Chg. -0.03 | Volume | Bid02:00:00 | Ask02:00:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1.12USD | -2.61% | 45,157 Turnover: 49,495.29 |
1.13Bid Size: 100 | 1.20Ask Size: 100 | 57.63 mill.USD | - | 2.73 |
Assets
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 8.6000 | 7.7300 | 7.9480 | 8.2140 | 7.9010 | ||||||
Intangible Assets | 9.9000 | 8.1080 | 6.1550 | 4.4220 | 2.8950 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | 23.6750 | 21.9080 | 20.4240 | 18.5810 | ||||||
Inventories | 8.8000 | 8.6900 | 7.3960 | 6.9710 | 7.0470 | ||||||
Accounts Receivable | 12.3000 | 12.4700 | 12.1090 | 14.5920 | 15.1800 | ||||||
Cash and Cash Equivalents | 9 | 17.4550 | 18.1090 | 67.7770 | 64.1670 | ||||||
Current Assets | 32.6000 | 40.7360 | 46.4860 | 91.3970 | 89.0840 | ||||||
Total Assets | 59 | 64.4110 | 68.3940 | 111.8210 | 107.6650 |
Liabilities
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 8.5000 | 8.2450 | 8.7620 | 9.8570 | 10.3500 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 12 | 13.1000 | 11.3400 | 8.2000 | 6.7000 | ||||||
Liabilities | 24.8000 | 27.4610 | 25.7880 | 22.2670 | 18.7930 | ||||||
Share Capital | .4000 | .4430 | .4610 | .4630 | - | ||||||
Total Equity | 34.1000 | 36.9500 | 42.6060 | 89.5540 | 88.8720 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 59 | 64.4110 | 68.3940 | 111.8210 | 107.6650 |
Income Statement
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 93.7000 | 95.9470 | 97.5990 | 102.7730 | 107.8040 | ||||||
Depreciation (total) | - | 3.9710 | 3.7890 | 3.8400 | 3.5980 | ||||||
Operating Result | -19 | -10.1800 | -1.2060 | 47.0030 | -3.0660 | ||||||
Interest Income | -.0500 | -.2080 | -.2450 | -.1360 | .3840 | ||||||
Income Before Taxes | -18.9000 | -9.9050 | -2.2920 | 46.5150 | -2.4220 | ||||||
Income Taxes | -.7000 | .0720 | -.0070 | 1.2290 | .0820 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | -18.2000 | -9.9770 | -2.2850 | 45.2860 | -2.5040 |
Per Share
Cash Flow
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -10 | -1.6970 | -3.7000 | 53.1260 | -.2050 | ||||||
Cash Flow from Investing Activities | -1 | -.8330 | -1.7520 | -1.5120 | -1.7490 | ||||||
Cash Flow from Financing | 4.8000 | 10.9170 | 6.2250 | -1.9310 | -1.6690 | ||||||
Decrease / Increase in Cash | -6.1000 | 8.4480 | .6540 | 49.6680 | -3.6100 | ||||||
Employees | 423 | 475 | 483 | 489 | 472 |